Vector Science appoints Russell Starr as president
Vector Science & Therapeutics appointed Russell Starr as president, effective Oct. 5, 2026. Starr is a capital markets executive with experience in complex financings, strategic transactions, public listings, corporate development. Appointment adds a senior leadership role as the company targets its next growth phase i